Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development
Expert Review of Clinical Pharmacology · 2026
DOI: 10.1080/17512433.2026.2620530 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Expert Review of Clinical Pharmacology, 2026. Verfasst von Ibrahim El-Haffaf und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada. Hauptthemen laut MEDLINE: Piperacillin, Anti-Bacterial Agents, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Canadian Society of Hospital Pharmacists, Université de Montréal.
Abstract (Originalsprache)
BACKGROUND: Piperacillin population pharmacokinetic models reportedly perform poorly for critically ill females compared to males. We aimed to explore potential methods that may better adjust for female data during model development. RESEARCH DESIGN AND METHODS: Total piperacillin concentrations were used from a prospective observational study in NONMEM v7.5.1. Two models were developed following different approaches: classic stepwise approach and sex-specific approach. Relationship between covariates and estimated parameters were explored by statistically and graphically assessing their performance on males and females separately. Dosing regimen simulations were also performed separately by sex. RESULTS: A one-compartment model based on data from 70 critically ill patients (49/21 males/females) with 233 concentrations best fit the data with both approaches. Creatinine clearance was the most significant covariate for the classic approach model, while creatinine clearance was best for male patients and estimated glomerular filtration rate was best for female patients with the sex-specific approach. Dosing recommendations were different between male and female patients with the sex-specific model. CONCLUSION: This study is the first to consider sex-specific covariates during the modeling process for piperacillin in critically ill patients. This approach may help reduce differences in model predictions between males and females in model-informed precision dosing strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.
- Laboratoire de Suivi Thérapeutique Pharmacologique et Pharmacocinétique, Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.
- CIUSSS-NIM-Hôpital du Sacré-Cœur de Montréal and CIUSSS-NIM Research Center, Montréal, QC, Canada.
- Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
- Department of Pharmacy, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
- Centre de Recherche, CHU Sainte-Justine, Montréal, QC, Canada.
ORCID-Profile: Ibrahim El-Haffaf
Förderung
- Canadian Society of Hospital Pharmacists
- Université de Montréal
Zitieren
APA
El-Haffaf, I., Williamson, D., Nguyen, V. D., Duong, A., Williams, V., Smith, M. A., Albert, M., Blain, H., Goettel, N., Beloin-Jubinville, B., Lamontagne, F., & Marsot, A. (2026). Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2026.2620530
Vancouver
El-Haffaf I, Williamson D, Nguyen VD, Duong A, Williams V, Smith MA, et al. Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development. Expert Review of Clinical Pharmacology. 2026. doi:10.1080/17512433.2026.2620530
BibTeX
@article{ElHaffaf2026,
author = {El-Haffaf, Ibrahim and Williamson, David and Nguyen, Van Dong and Duong, Alexandre and Williams, Virginie and Smith, Marc-André and Albert, Martin and Blain, Hugues and Goettel, Nicolas and Beloin-Jubinville, Bianca and Lamontagne, François and Marsot, Amélie},
title = {Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
doi = {10.1080/17512433.2026.2620530}
}
EUVIMED